Prevalence of Hidradenitis Suppurativa in Lyon: Results from the French Team of the Global Hidradenitis Suppurativa Atlas Project.

IF 2.7 3区医学 Q2 DERMATOLOGY

Dermatology Pub Date : 2025-07-07 DOI:10.1159/000542671

Philippe Guillem, Virginie Vlaeminck-Guillem, Marianne Beuque-Lévèque, Christelle Chavrier, Marion Clerbout, Christelle Enault, Inès Evain, Myriam Fioretta, Anne-Sophie Gadat, Samantha Gaspard, Sylvia Math, Gregor B E Jemec, Dorra Bouazzi

{"title":"Prevalence of Hidradenitis Suppurativa in Lyon: Results from the French Team of the Global Hidradenitis Suppurativa Atlas Project.","authors":"Philippe Guillem, Virginie Vlaeminck-Guillem, Marianne Beuque-Lévèque, Christelle Chavrier, Marion Clerbout, Christelle Enault, Inès Evain, Myriam Fioretta, Anne-Sophie Gadat, Samantha Gaspard, Sylvia Math, Gregor B E Jemec, Dorra Bouazzi","doi":"10.1159/000542671","DOIUrl":null,"url":null,"abstract":"Introduction: The exact prevalence of hidradenitis suppurativa (HS) remains elusive, in France as elsewhere. The Global Hidradenitis Suppurativa Atlas (GHiSA) project is a unique opportunity not only to determine the exact prevalence in each participating center but also to help estimate the global prevalence and provide a basis for comparing centers with each other and obtaining potential pathophysiological indications.Methods: A French version of the questionnaire developed for the GHiSA initiative was proposed to healthy adults accompanying a patient to the outpatient clinic.Results: The prevalence of HS in the 525 participants was 3.43% (95% confidence interval: 2.2%-5.4%). The HS patients were 10 females and 8 males and were significantly younger than non-HS controls and more frequently smokers. The screening questionnaire showed a 100% sensitivity and negative predictive value.Conclusion: The estimated prevalence here is more than three times higher than the 1% prevalence usually recognized in Western countries. It remains to be determined whether this increase is apparent (freedom of speech; methodological differences compared with previous studies, which contribute to the usual figure of 1%) or real. In the latter case (gross increase in the prevalence of the disease), the underlying mechanisms need to be explored, and comparison with the results observed in other GHiSA centers will be decisive.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233959/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542671","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The exact prevalence of hidradenitis suppurativa (HS) remains elusive, in France as elsewhere. The Global Hidradenitis Suppurativa Atlas (GHiSA) project is a unique opportunity not only to determine the exact prevalence in each participating center but also to help estimate the global prevalence and provide a basis for comparing centers with each other and obtaining potential pathophysiological indications.

Methods: A French version of the questionnaire developed for the GHiSA initiative was proposed to healthy adults accompanying a patient to the outpatient clinic.

Results: The prevalence of HS in the 525 participants was 3.43% (95% confidence interval: 2.2%-5.4%). The HS patients were 10 females and 8 males and were significantly younger than non-HS controls and more frequently smokers. The screening questionnaire showed a 100% sensitivity and negative predictive value.

Conclusion: The estimated prevalence here is more than three times higher than the 1% prevalence usually recognized in Western countries. It remains to be determined whether this increase is apparent (freedom of speech; methodological differences compared with previous studies, which contribute to the usual figure of 1%) or real. In the latter case (gross increase in the prevalence of the disease), the underlying mechanisms need to be explored, and comparison with the results observed in other GHiSA centers will be decisive.

查看原文本刊更多论文

里昂化脓性汗腺炎的患病率：来自全球化脓性汗腺炎地图集项目法国团队的结果。

简介：化脓性汗腺炎（HS）的确切患病率仍然难以捉摸，在法国和其他地方。全球化脓性汗腺炎地图集（GHiSA）项目是一个独特的机会，不仅可以确定每个参与中心的确切患病率，还可以帮助估计全球患病率，并为中心之间的比较和获得潜在的病理生理指征提供基础。方法：对陪同患者到门诊就诊的健康成人提出了一份为GHiSA倡议开发的法语版问卷。结果：525名参与者HS患病率为3.43%（95%可信区间为2.2% ~ 5.4%）。HS患者中女性10名，男性8名，明显比非HS对照组年轻，吸烟频率更高。筛选问卷的敏感性为100%，预测值为阴性。结论：这里的估计患病率比西方国家通常认为的1%的患病率高出三倍以上。这种增长是否明显还有待确定(言论自由；与以前的研究相比，方法上的差异（通常为1%）或真实的。在后一种情况下（疾病患病率的总体增加），需要探索潜在的机制，并与其他GHiSA中心观察到的结果进行比较将是决定性的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dermatology 医学-皮肤病学

CiteScore

6.40

自引率

2.90%

发文量

审稿时长

1 months

期刊介绍： Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.